FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13601411000001103: Tritace 5mg tablets (sanofi-aventis) 21 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
48446701000001112 Tritace 5mg tablets (sanofi-aventis) 21 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
65969001000001112 Tritace 5mg tablets (Sanofi) 21 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tritace 5mg tablets (sanofi-aventis) 21 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tritace 5mg tablets (sanofi-aventis) 21 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tritace 5mg tablets (sanofi-aventis) 21 tablet Is a Ramipril 5mg tablets 21 tablet true Inferred relationship Existential restriction modifier
Tritace 5mg tablets (sanofi-aventis) 21 tablet Is pack of Tritace 5mg tablets (Aventis Pharma) false Inferred relationship Existential restriction modifier
Tritace 5mg tablets (sanofi-aventis) 21 tablet Has active ingredient Ramipril false Inferred relationship Existential restriction modifier
Tritace 5mg tablets (sanofi-aventis) 21 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Tritace 5mg tablets (sanofi-aventis) 21 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tritace 5mg tablets (sanofi-aventis) 21 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tritace 5mg tablets (sanofi-aventis) 21 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tritace 5mg tablets (sanofi-aventis) 21 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Tritace 5mg tablets (sanofi-aventis) 21 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Tritace 5mg tablets (sanofi-aventis) 21 tablet Has AMP Tritace 5mg tablets (Aventis Pharma) true Inferred relationship Existential restriction modifier
Tritace 5mg tablets (sanofi-aventis) 21 tablet Has specific active ingredient Ramipril true Inferred relationship Existential restriction modifier
Tritace 5mg tablets (sanofi-aventis) 21 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tritace 5mg tablets (sanofi-aventis) 21 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start